Effluxing ABC transporters in human corneal epithelium.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 2906233)

Published in J Pharm Sci on February 01, 2010

Authors

Kati-Sisko Vellonen1, Eliisa Mannermaa, Helen Turner, Marika Häkli, J Mario Wolosin, Timo Tervo, Paavo Honkakoski, Arto Urtti

Author Affiliations

1: Centre for Drug Research, University of Helsinki, Helsinki, Finland.

Articles citing this

Ocular drug delivery. AAPS J (2010) 2.19

Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci (2010) 0.98

DUSP5 and DUSP6 modulate corneal epithelial cell proliferation. Mol Vis (2010) 0.88

The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels. Int J Nanomedicine (2013) 0.85

Passive asymmetric transport of hesperetin across isolated rabbit cornea. Int J Pharm (2010) 0.82

Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters. J Ocul Pharmacol Ther (2015) 0.82

Functional and molecular aspects of biotin uptake via SMVT in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells. AAPS J (2012) 0.81

Gene expression analysis in SV-40 immortalized human corneal epithelial cells cultured with an air-liquid interface. Mol Vis (2010) 0.81

Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures. Mol Pharm (2013) 0.80

Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility. J Ocul Pharmacol Ther (2013) 0.77

Human corneal cell culture models for drug toxicity studies. Drug Deliv Transl Res (2016) 0.75

Prodrug strategies in ocular drug delivery. Med Chem (2012) 0.75

Nanostructured materials for ocular delivery: nanodesign for enhanced bioadhesion, transepithelial permeability and sustained delivery. Ther Deliv (2015) 0.75

Articles cited by this

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (1992) 8.84

A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A (1998) 6.47

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol (2005) 3.34

Characterization of putative stem cell phenotype in human limbal epithelia. Stem Cells (2004) 2.73

Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res (1997) 2.67

ABCG2 transporter identifies a population of clonogenic human limbal epithelial cells. Stem Cells (2005) 1.95

Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem (2002) 1.86

Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A (2000) 1.83

The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem (2000) 1.76

Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells. J Cell Sci (2005) 1.75

The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab (2004) 1.67

Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem (2003) 1.63

MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A (1999) 1.59

Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch (2006) 1.58

Human limbal epithelium contains side population cells expressing the ATP-binding cassette transporter ABCG2. FEBS Lett (2004) 1.51

Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm Res (2009) 1.46

Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev (2006) 1.46

Characterization of uptake and hydrolysis of fluorescein diacetate and carboxyfluorescein diacetate by intracellular esterases in Saccharomyces cerevisiae, which result in accumulation of fluorescent product. Appl Environ Microbiol (1995) 1.43

Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry (1998) 1.41

Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem Biophys Res Commun (2001) 1.33

Ocular surface epithelial and stem cell development. Int J Dev Biol (2004) 1.32

Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience (2004) 1.30

The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther (2005) 1.29

Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J Pharmacol Exp Ther (2004) 1.24

Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophthalmol Vis Sci (2001) 1.24

The distribution of Abcc6 in normal mouse tissues suggests multiple functions for this ABC transporter. J Histochem Cytochem (2003) 1.23

Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev (2005) 1.22

Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. Invest Ophthalmol Vis Sci (2003) 1.21

Acute wound healing in the human central corneal epithelium appears to be independent of limbal stem cell influence. Invest Ophthalmol Vis Sci (2008) 1.17

Topical medical therapies for ocular surface tumors. Semin Ophthalmol (2006) 1.15

Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). Pflugers Arch (2006) 1.11

Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metab Dispos (2006) 1.11

Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. J Pharm Sci (1987) 1.08

Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition. Drug Metab Dispos (2008) 1.07

Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption. J Pharmacol Exp Ther (2004) 1.03

Pharmacokinetics of 5 (and 6)-carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liver. J Pharmacol Exp Ther (2003) 1.03

P-glycoprotein expression in human retinal pigment epithelium. Mol Vis (2002) 1.03

pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem (1999) 1.01

Genomic aberrations and cellular heterogeneity in SV40-immortalized human corneal epithelial cells. Invest Ophthalmol Vis Sci (2008) 1.00

Cancer chemoresistance: the relationship between p53 and multidrug transporters. Int J Cancer (2002) 0.98

Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem (1997) 0.98

Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. Eur J Pharm Sci (2004) 0.96

Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J Biol Chem (2002) 0.96

Corneal penetration behavior of beta-blocking agents II: Assessment of barrier contributions. J Pharm Sci (1983) 0.93

Molecular evidence and functional expression of multidrug resistance associated protein (MRP) in rabbit corneal epithelial cells. Exp Eye Res (2006) 0.92

Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J Pharmacol Exp Ther (2004) 0.90

Short-term regulation of multidrug resistance-associated protein 3 in rat and human hepatocytes. Am J Physiol Gastrointest Liver Physiol (2005) 0.88

Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. Eur J Pharm Sci (2001) 0.88

Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. Invest Ophthalmol Vis Sci (1999) 0.87

ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int (2000) 0.87

Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells. Antimicrob Agents Chemother (2000) 0.86

Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs. Curr Drug Metab (2007) 0.85

Identification and localization of aquaporin 5 in the mammalian conjunctival epithelium. Exp Eye Res (2006) 0.85

Expression of ABC-transporters in human corneal tissue and the transformed cell line, HCE-T. J Ocul Pharmacol Ther (2007) 0.85

Presence of CFTR in the conjunctival epithelium. Curr Eye Res (2002) 0.85

Effects of clotrimazole on transport mediated by multidrug resistance associated protein 1 (MRP1) in human erythrocytes and tumour cells. Eur J Biochem (2001) 0.84

Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport. Eur J Pharm Sci (2005) 0.83

Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. Eur J Pharm Sci (2003) 0.81

Corneal epithelium as a platform for secretion of transgene products after transfection with liposomal gene eyedrops. J Gene Med (2007) 0.80

Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines. Eur J Pharm Sci (2005) 0.80

Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit. Pharm Res (1991) 0.80

Characterization of serotonergic receptors in rabbit, porcine and human conjunctivae. Curr Eye Res (2003) 0.78

Improved corneal pilocarpine permeability with O,O'-(1,4-xylylene) bispilocarpic acid ester double prodrugs. Pharm Res (1991) 0.76

Articles by these authors

Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol (2008) 2.02

Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells. J Cell Sci (2005) 1.75

Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol (2003) 1.75

The RABIT: a rapid automated biodosimetry tool for radiological triage. Health Phys (2010) 1.69

A locus for autosomal dominant keratoconus: linkage to 16q22.3-q23.1 in Finnish families. Invest Ophthalmol Vis Sci (2002) 1.66

Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci (2008) 1.62

Different cell sizes in human limbal and central corneal basal epithelia measured by confocal microscopy and flow cytometry. Invest Ophthalmol Vis Sci (2003) 1.53

Gold nanoparticles enable selective light-induced contents release from liposomes. J Control Release (2007) 1.46

Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev (2006) 1.46

Applying linear and non-linear methods for parallel prediction of volume of distribution and fraction of unbound drug. PLoS One (2013) 1.43

Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today (2008) 1.33

A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J Exp Med (2004) 1.25

Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci (2005) 1.24

LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. J Refract Surg (2008) 1.23

An update on the constitutive androstane receptor (CAR). Drug Metabol Drug Interact (2013) 1.16

Crosstalk between Hsp70 molecular chaperone, lysosomes and proteasomes in autophagy-mediated proteolysis in human retinal pigment epithelial cells. J Cell Mol Med (2008) 1.14

Cell culture models of the ocular barriers. Eur J Pharm Biopharm (2005) 1.11

Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling. Adv Drug Deliv Rev (2006) 1.09

Comparative analysis of human conjunctival and corneal epithelial gene expression with oligonucleotide microarrays. Invest Ophthalmol Vis Sci (2007) 1.09

A randomized, double-blind comparison study of EMLA and ELA-Max for topical anesthesia in children undergoing intravenous insertion. Paediatr Anaesth (2004) 1.08

Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. J Control Release (2002) 1.07

The effect and role of carbon atoms in poly(β-amino ester)s for DNA binding and gene delivery. J Am Chem Soc (2013) 1.06

Formation of a physiological complex between TRPV2 and RGA protein promotes cell surface expression of TRPV2. J Cell Biochem (2005) 1.03

Including culturally diverse samples in health research: a case study of an urban trial of social support. Ethn Health (2003) 1.03

TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD. Cell Signal (2006) 1.01

Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties. Eur J Pharm Sci (2004) 0.99

Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci (2010) 0.98

Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol (2002) 0.98

Extracellular and intracellular barriers in non-viral gene delivery. J Control Release (2003) 0.97

sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised. Exp Eye Res (2008) 0.97

Efflux protein expression in human retinal pigment epithelium cell lines. Pharm Res (2009) 0.97

Secretogranin III directs secretory vesicle biogenesis in mast cells in a manner dependent upon interaction with chromogranin A. J Immunol (2008) 0.96

Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. Eur J Pharm Sci (2004) 0.96

RGA protein associates with a TRPV ion channel during biosynthesis and trafficking. J Cell Biochem (2004) 0.96

Alginate-based microencapsulation of retinal pigment epithelial cell line for cell therapy. Biomaterials (2007) 0.95

p62/sequestosome 1 as a regulator of proteasome inhibitor-induced autophagy in human retinal pigment epithelial cells. Mol Vis (2010) 0.95

Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. J Gene Med (2004) 0.95

P63 expression levels in side population and low light scattering ocular surface epithelial cells. Trans Am Ophthalmol Soc (2005) 0.95

Computational prediction of oral drug absorption based on absorption rate constants in humans. J Med Chem (2006) 0.94

Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? PLoS One (2012) 0.94

TRPV1 potentiates TGFβ-induction of corneal myofibroblast development through an oxidative stress-mediated p38-SMAD2 signaling loop. PLoS One (2013) 0.93

Comparison of rat epidermal keratinocyte organotypic culture (ROC) with intact human skin: lipid composition and thermal phase behavior of the stratum corneum. Biochim Biophys Acta (2008) 0.91

Gold-embedded photosensitive liposomes for drug delivery: triggering mechanism and intracellular release. J Control Release (2010) 0.91

Ligand recognition by drug-activated nuclear receptors PXR and CAR: structural, site-directed mutagenesis and molecular modeling studies. Mini Rev Med Chem (2006) 0.91

Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers. Pharm Res (2003) 0.90

Regulation of the human tyrosinase gene in retinal pigment epithelium cells: the significance of transcription factor orthodenticle homeobox 2 and its polymorphic binding site. Mol Vis (2012) 0.90

Mechanisms of polyethylenimine-mediated DNA delivery: free carrier helps to overcome the barrier of cell-surface glycosaminoglycans. J Gene Med (2011) 0.90

ABCG2-dependent dye exclusion activity and clonal potential in epithelial cells continuously growing for 1 month from limbal explants. Invest Ophthalmol Vis Sci (2011) 0.90

Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system. Biomaterials (2012) 0.90

Barrier analysis of periocular drug delivery to the posterior segment. J Control Release (2010) 0.90

Amino acids important for ligand specificity of the human constitutive androstane receptor. J Biol Chem (2004) 0.89

Collagenolytic proteinases in keratoconus. Cornea (2006) 0.89

Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2. J Biol Chem (2005) 0.89

The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells. Immunol Lett (2007) 0.89

EMMPRIN and MMP-1 in keratoconus. Cornea (2006) 0.89

Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells. Eur J Pharmacol (2008) 0.88

Simultaneous determination of eight beta-blockers by gradient high-performance liquid chromatography with combined ultraviolet and fluorescence detection in corneal permeability studies in vitro. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.88

Impact of protein binding on the analytical detectability and anticancer activity of thymoquinone. J Chem Biol (2011) 0.88

Polyplex-mediated gene transfer and cell cycle: effect of carrier on cellular uptake and intracellular kinetics, and significance of glycosaminoglycans. J Gene Med (2007) 0.88

Precisely defined protein-polymer conjugates: construction of synthetic DNA binding domains on proteins by using multivalent dendrons. ACS Nano (2007) 0.88

Molecular profiling of conjunctival epithelial side-population stem cells: atypical cell surface markers and sources of a slow-cycling phenotype. Invest Ophthalmol Vis Sci (2009) 0.88

DUSP5 and DUSP6 modulate corneal epithelial cell proliferation. Mol Vis (2010) 0.88

Paracellular porosity and pore size of the human intestinal epithelium in tissue and cell culture models. J Pharm Sci (2010) 0.87

Small nuclear RING finger protein stimulates the rat luteinizing hormone-beta promoter by interacting with Sp1 and steroidogenic factor-1 and protects from androgen suppression. Mol Endocrinol (2004) 0.87

Generation of hESC-derived retinal pigment epithelium on biopolymer coated polyimide membranes. Biomaterials (2012) 0.87

Freeze-drying of cationic polymer DNA complexes enables their long-term storage and reverse transfection of post-mitotic cells. J Control Release (2005) 0.87

Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium. Pharm Res (2007) 0.87

Altered expression of type XIII collagen in keratoconus and scarred human cornea: Increased expression in scarred cornea is associated with myofibroblast transformation. Cornea (2006) 0.86

Dioleoyl phosphatidylethanolamine and PEG-lipid conjugates modify DNA delivery mediated by 1,4-dihydropyridine amphiphiles. J Control Release (2004) 0.86

Dual action of oestrogens on the mouse constitutive androstane receptor. Biochem J (2003) 0.86

Differential gene expression in the pig limbal side population: implications for stem cell cycling, replication, and survival. Invest Ophthalmol Vis Sci (2009) 0.86

High-throughput screening of cell responses to biomaterials. Eur J Pharm Sci (2008) 0.86

Beyond apoptosis: the mechanism and function of phosphatidylserine asymmetry in the membrane of activating mast cells. Bioarchitecture (2014) 0.86

Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship. J Med Chem (2008) 0.85

Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers. J Control Release (2004) 0.85

Role of polyplex intermediate species on gene transfer efficiency: polyethylenimine-DNA complexes and time-resolved fluorescence spectroscopy. J Phys Chem B (2011) 0.85

Nanofibrillar cellulose hydrogel promotes three-dimensional liver cell culture. J Control Release (2012) 0.85

The role of cell cycle on polyplex-mediated gene transfer into a retinal pigment epithelial cell line. J Gene Med (2005) 0.85

Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines. Eur J Pharm Biopharm (2007) 0.85

Pre-targeting and direct immunotargeting of liposomal drug carriers to ovarian carcinoma. PLoS One (2012) 0.85

Time-resolved fluorescence spectroscopy reveals functional differences of cationic polymer-DNA complexes. J Am Chem Soc (2008) 0.85

Functional TRPV1 expression in human corneal fibroblasts. Exp Eye Res (2012) 0.84

Impact of probe compound in MRP2 vesicular transport assays. Eur J Pharm Sci (2012) 0.84

Passive oral drug absorption can be predicted more reliably by experimental than computational models--fact or myth. Eur J Pharm Sci (2008) 0.84

Effects of chronic bhang (cannabis) administration on the reproductive system of male mice. Birth Defects Res B Dev Reprod Toxicol (2011) 0.84